Mikkeli Central Hospital
16
4
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
High Flow Nasal Cannula Weaning in Acute Bronchiolitis
Role: collaborator
Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome
Role: collaborator
Incidence and Outcome of Acute Diverticulitis in Finland
Role: collaborator
Open and Endoscopic Technique in Female Inguinal Hernia Repair. FemaleHernia
Role: collaborator
Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis
Role: collaborator
SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)
Role: collaborator
SOLIDARITY Finland Plus Long-COVID
Role: collaborator
Postoperative Pain After Endoscopic TEP vs. Lichtenstein Hernioplasty in Inguinal Hernia Repair
Role: collaborator
Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients
Role: collaborator
Groin Injuries in Finnish Contact Sports
Role: collaborator
The Prevalence of Appendiceal Tumours in Periappendicular Abscess
Role: collaborator
Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis
Role: collaborator
The Finnish Faecal Microbiota Transplantation Study (FINFMT)
Role: collaborator
First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02
Role: collaborator
Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis
Role: collaborator
Comparison of Three Meshes in Lichtenstein Hernia Repair
Role: collaborator
All 16 trials loaded